# Change of Gut Microbiome and Symptom After H.Pylori Eradication Therapy in Patients With Functional Dyspepsia

> **NCT04449185** · PHASE4 · UNKNOWN · sponsor: **Asan Medical Center** · enrollment: 60 (estimated)

## Conditions studied

- Dyspepsia

## Interventions

- **DRUG:** Tegoprazan 50mg bid + amoxicillin 1000mg bid + clarithromycin 500mg bid for 10 days

## Key facts

- **NCT ID:** NCT04449185
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-30
- **Primary completion:** 2021-10-30
- **Final completion:** 2021-10-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2020-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04449185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04449185, "Change of Gut Microbiome and Symptom After H.Pylori Eradication Therapy in Patients With Functional Dyspepsia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04449185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*